Development
Traws Pharma, Inc.
TRAW
$1.50
-$0.022-1.45%
NASDAQ
| 09/30/2023 | 06/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 1.79% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 1.79% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 0.00% | 1.79% | |||
| SG&A Expenses | 21.48% | 4.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.26% | -24.64% | |||
| Operating Income | -10.39% | 24.88% | |||
| Income Before Tax | -11.51% | 26.41% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -11.51% | 26.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -11.51% | 26.41% | |||
| EBIT | -10.39% | 24.88% | |||
| EBITDA | -10.38% | 24.91% | |||
| EPS Basic | -11.35% | 26.46% | |||
| Normalized Basic EPS | -11.37% | 26.48% | |||
| EPS Diluted | -11.35% | 27.64% | |||
| Normalized Diluted EPS | -11.37% | 26.48% | |||
| Average Basic Shares Outstanding | 0.11% | 0.09% | |||
| Average Diluted Shares Outstanding | 0.11% | 0.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||